These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
351 related articles for article (PubMed ID: 14631226)
1. The need for a prophylactic gastrojejunostomy for unresectable periampullary cancer: a prospective randomized multicenter trial with special focus on assessment of quality of life. Van Heek NT; De Castro SM; van Eijck CH; van Geenen RC; Hesselink EJ; Breslau PJ; Tran TC; Kazemier G; Visser MR; Busch OR; Obertop H; Gouma DJ Ann Surg; 2003 Dec; 238(6):894-902; discussion 902-5. PubMed ID: 14631226 [TBL] [Abstract][Full Text] [Related]
2. Is prophylactic gastrojejunostomy indicated for unresectable periampullary cancer? A prospective randomized trial. Lillemoe KD; Cameron JL; Hardacre JM; Sohn TA; Sauter PK; Coleman J; Pitt HA; Yeo CJ Ann Surg; 1999 Sep; 230(3):322-8; discussion 328-30. PubMed ID: 10493479 [TBL] [Abstract][Full Text] [Related]
3. Complications of palliative hepaticojejunostomy and gastrojejunostomy in unresectable periampullary cancer: patient- and disease-related risk factors. Räty S; Sand J; Piironen A; Nordback I Hepatogastroenterology; 2006; 53(67):133-7. PubMed ID: 16506392 [TBL] [Abstract][Full Text] [Related]
8. Randomized trial of gastrojejunostomy with duodenal partition versus antrectomy in unresectable periampullary cancer. Shyr YM; Su CH; Wu CW; Lui WY Zhonghua Yi Xue Za Zhi (Taipei); 2001 Aug; 64(8):443-50. PubMed ID: 11720142 [TBL] [Abstract][Full Text] [Related]
9. Staging laparoscopy in patients scheduled for pancreaticoduodenectomy minimizes hospitalization in the remaining life time when metastatic carcinoma is found. Beenen E; van Roest MH; Sieders E; Peeters PM; Porte RJ; de Boer MT; de Jong KP Eur J Surg Oncol; 2014 Aug; 40(8):989-94. PubMed ID: 24582004 [TBL] [Abstract][Full Text] [Related]
11. Palliation of unresectable periampullary neoplasms. "surgical" versus "non-surgical" approach. Nuzzo G; Clemente G; Cadeddu F; Giovannini I Hepatogastroenterology; 2004; 51(59):1282-5. PubMed ID: 15362733 [TBL] [Abstract][Full Text] [Related]
12. Combined biliary and gastric bypass procedures as effective palliation for unresectable malignant disease. Mann CD; Thomasset SC; Johnson NA; Garcea G; Neal CP; Dennison AR; Berry DP ANZ J Surg; 2009 Jun; 79(6):471-5. PubMed ID: 19566872 [TBL] [Abstract][Full Text] [Related]
13. Randomized trial of three types of gastrojejunostomy in unresectable periampullary cancer. Shyr YM; Su CH; King KL; Wang HC; Lo SS; Wu CW; Lui WY Surgery; 1997 May; 121(5):506-12. PubMed ID: 9142148 [TBL] [Abstract][Full Text] [Related]
14. Endo-laparoscopic approach in the management of obstructive jaundice and malignant gastric outflow obstruction. Tang CN; Siu WT; Ha JP; Li MK Hepatogastroenterology; 2005; 52(61):128-34. PubMed ID: 15783012 [TBL] [Abstract][Full Text] [Related]
20. A wait-and-see strategy with subsequent self-expanding metal stent on demand is superior to prophylactic bypass surgery for unresectable periampullary cancer. Williamsson C; Wennerblom J; Tingstedt B; Jönsson C HPB (Oxford); 2016 Jan; 18(1):107-12. PubMed ID: 26776858 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]